Ochratoxin A Test

Certain molds that grow on everyday foods produce a poison called Ochratoxin A (OTA) that you cannot see, smell, or taste. Once you eat contaminated food, OTA binds tightly to proteins in your blood and clears very slowly, with a half-life (the time it takes for half the toxin to leave your body) of roughly five weeks in humans. That slow clearance means even modest, repeated exposure can build up over time, and your kidneys bear the brunt of the damage.

This urine test tells you whether OTA is accumulating in your body. Unlike a standard kidney panel that picks up damage after it has already happened, urinary OTA can reveal ongoing toxic exposure while your kidneys still look fine on routine labs. If your level is elevated, you have a concrete signal to investigate your diet, your home environment, or both.

What This Test Actually Measures

OTA is not something your body makes. It is a toxic byproduct (called a mycotoxin) produced by Aspergillus and Penicillium molds as they grow on crops and stored food. When you eat contaminated food, OTA enters your bloodstream, binds strongly to a blood protein called albumin, and is eventually filtered out through your kidneys into your urine. This test measures OTA in your urine, which reflects recent exposure and your kidneys' ongoing effort to eliminate the toxin.

Because OTA sticks to blood proteins and clears so slowly, even a single urine measurement captures a meaningful window of exposure. A detectable result means your body has been processing this toxin. A high result means your exposure is significant enough to warrant investigation.

Where Exposure Comes From

OTA contamination is widespread. Modern analytical methods suggest that 60 to 80% of food crops worldwide may carry detectable levels of at least one mycotoxin. OTA specifically turns up most often in cereals and grain products, coffee, cocoa, dried fruits, wine, and spices. It is heat-stable, meaning cooking and baking reduce but do not eliminate it.

Beyond food, people living or working in water-damaged buildings can inhale OTA from indoor mold growth. In one study of 112 patients with chronic fatigue syndrome who had heavy exposure to water-damaged buildings, 83% had detectable urinary OTA, compared with none of the 55 unexposed controls. If you suspect mold in your home or workplace, this test can help determine whether the exposure is reaching your body.

Kidney Damage

The kidneys are OTA's primary target. The toxin concentrates in kidney tissue and damages the tubes that filter your blood, triggering inflammation, scarring, and loss of function over time. Based mainly on animal and laboratory studies, OTA appears to cause this damage through several routes: it generates unstable oxygen molecules (called reactive oxygen species) that injure cells, it disrupts the energy-producing structures inside cells (called mitochondria), and it interferes with normal protein production.

One systematic review of all available human evidence found that a small Egyptian study showed people with very high urinary OTA (averaging 3.09 ng/mL) had roughly 10 times the odds of nephrotic syndrome (a pattern of heavy protein loss in the urine) compared to controls. Other kidney conditions studied, including end-stage renal disease, showed elevated but not statistically significant associations. The authors noted that none of these studies controlled for other risk factors, so the precise contribution of OTA remains uncertain.

OTA has also been investigated as a possible contributor to Balkan endemic nephropathy, a chronic kidney disease concentrated in rural communities along the Danube River basin. Studies from these regions have found higher blood OTA levels in affected villages compared to nearby unaffected ones, but a definitive causal link has not been established.

Cancer Risk

The International Agency for Research on Cancer classifies OTA as a Group 2B agent, meaning it is a possible human carcinogen. This classification is based on clear evidence that OTA causes kidney tumors in animals and on the observation that it damages DNA and promotes the kind of cellular changes that precede cancer.

In a small human study, OTA was found in 76% of kidney and tumor tissue samples from 33 patients with a type of kidney cancer called renal cell carcinoma. Some OTA breakdown products in those tissues correlated with signs of DNA damage, suggesting a direct link between the toxin and the tumor. A systematic review of mycotoxin exposure and human cancer risk concluded that while the biological plausibility is strong, more and larger human studies are needed before the association can be considered confirmed.

Immune Suppression

A systematic review of OTA's effects on the immune system found that the toxin disrupts immune organ function, reduces the production of antibody-secreting cells, and weakens the barrier lining of the gut and airways. Most of this evidence comes from animal studies, so the degree to which these effects translate to typical human exposure levels is still being studied. However, the combination of kidney damage, potential cancer promotion, and immune suppression makes OTA one of the more concerning mycotoxins from a health perspective.

Understanding Your Results

There are no universally standardized clinical cutpoints for urinary OTA. This test is primarily an exposure marker, and regulatory bodies frame safety in terms of how much OTA you take in per day relative to your body weight, not in terms of a single urine concentration. That said, population biomonitoring studies provide useful orientation.

The following context comes from biomonitoring studies across multiple countries. These are not clinical thresholds but rather benchmarks to help you interpret where your result falls relative to general populations.

Biomonitoring studies show that OTA is nearly ubiquitous at low levels. In a Portuguese study of 104 adults, 100% had detectable serum OTA (a related blood-based measurement, ranging from 0.14 to 2.49 micrograms per liter). In a study of 85 Portuguese children, about 93% had detectable urinary OTA. Having a detectable level does not automatically mean you are at risk, but having a level well above the population average is a reason to investigate and retest.

When Results Can Be Misleading

Urinary OTA represents only a small fraction of total body burden, because most OTA remains bound to blood proteins rather than being filtered into urine. A low urinary result does not guarantee low total exposure. If you have strong reason to suspect exposure (visible mold at home, heavy consumption of high-risk foods), a blood-based OTA measurement captures longer-term, integrated exposure more reliably than a single urine sample.

• Hydration status: A very dilute urine sample can produce a falsely low OTA reading. Labs may report creatinine alongside OTA to adjust for urine concentration, but if your sample was extremely dilute, ask about retesting with a more concentrated specimen.
• Recent dietary change: If you recently eliminated high-risk foods like coffee, wine, or grains, your urinary OTA may drop quickly while your blood level remains elevated. A single urine test after a dietary shift may underestimate your ongoing body burden.
• Kidney function: If your kidneys are significantly impaired, they may filter less OTA into urine, producing a falsely reassuring urinary result even while the toxin accumulates in your blood and tissues.
• Other ochratoxins: This test measures OTA specifically. Other members of the ochratoxin family and their breakdown products are not captured, which means total ochratoxin exposure could be higher than this single measurement suggests.

Tracking Your Trend

A single OTA result is a snapshot, not a verdict. Research shows that OTA levels within the same person can vary meaningfully over time depending on diet, season, and environment. If your first result is elevated, the most useful next step is to identify and reduce likely exposure sources, then retest in 2 to 3 months to see whether your level has dropped.

If you are testing because of suspected mold exposure at home or work, get a baseline before remediation, then retest 8 to 12 weeks after the environment has been cleaned. OTA's slow clearance from the body means you will not see an immediate drop. Given the five-week half-life, it takes several months for levels to decline substantially after exposure stops.

For ongoing monitoring, testing once or twice per year is reasonable if you have a history of elevated results, live in a climate prone to mold, or consume large amounts of high-risk foods like coffee, grains, or wine. If your levels are consistently undetectable, annual testing is sufficient.

What to Do With an Elevated Result

An elevated urinary OTA should prompt two parallel investigations: your exposure sources and your kidney health.

For exposure, consider whether your diet is heavy in cereals, coffee, cocoa, dried fruits, wine, or spices, especially if sourced from regions with less rigorous food safety monitoring. If you live or work in a building with visible mold, water damage, or musty odors, professional mold testing and remediation should be a priority.

For your kidneys, order a basic kidney function panel (creatinine, cystatin C, eGFR, and a urine albumin-to-creatinine ratio) if you have not had one recently. These tests check whether your kidneys are already showing signs of the damage OTA is known to cause. If both your OTA and kidney markers are abnormal, a nephrologist (kidney specialist) can help determine whether the two are related and guide next steps. If your kidney function looks normal but OTA is elevated, focus on reducing exposure and retesting to confirm the level comes down.